Allergy & Asthma

Category: Pulmonary/Respiratory, HIC#14578
Title:
A Phase II Study in Patients with Asthma to Assess the Safety and Immunogenicity of an Unadjuvanted Novartis H1N1 Influenza Vaccine Administered at Two Dose Levels
Contact:William Teague
Phone:(434)243-0613
E-mail:wgt2p@Virginia.EDU

DO YOU HAVE ASTHMA?

We are currently recruiting for a clinical trial at the University of Virginia Health
System. This study will help us find out how the H1N1 Vaccine affects people with Asthma.

If you have been diagnosed with Asthma and have not received the H1N1 vaccine, you may be able to participate.

If you have received the seasonal flu vaccine you may participate, but you cannot receive the H1N1 vaccine for at least two weeks after the seasonal vaccine.

Compensation $485 upon completion of the trial.

For Further Information

Call 434-924-1781
OR
Email H1N1@virginia.edu

IRB HSR #14578
Primary Investigator: Teague William, G
Department: Pediatrics
Division: Allergy/Pulmonary/Cystic Fibrosis 		Accepts adult enrollment :YES
Accepts minor enrollment :YES